@WHO: WHO welcomes the addition of Casirivimab and Imdevimab to the list of therapeutics for treatment for #COVID19. We urge producing companies and governments to ensure equitable access across all regions, especially in low- and middle-income countries. https://t.co/dXmYDVb7Mi https://t.co/JwCM2iHLfy

@WHO: WHO welcomes the addition of Casirivimab and Imdevimab to the list of therapeutics for treatment for #COVID19. We urge producing companies and governments to ensure equitable access across all regions, especially in low- and middle-income countries. https://t.co/dXmYDVb7Mi https://t.co/JwCM2iHLfy

http://twitter.com/WHO
via IFTTT

Comments